...
PBYIMICRO

Puma Biotechnology, Inc.

HealthcareBiotechnology
$5.70
$0.01(-25.00%)
52W$2.58
$7.68
FinancialsValuationvs RVMD
Updated Feb 28, 12:00 AM
RSI70
RS Rating71/99
Beta0.54
Volatility73%
F-Score7/9
Mkt Cap$287M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Puma Biotechnology, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 71), indicating performance broadly in line with the market. Earnings contraction of 33% provides fundamental context to the price action. Investors should exercise caution due to high volatility (73% annualized), which requires wider risk management.

Relative Strength
71
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.54
vs S&P 500
DEFENSIVE
52W Position
61%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$6.46
50 SMA > 100 SMA$5.84
100 SMA > 150 SMA$5.42
150 SMA > 200 SMA$4.92

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.88-17.18%BELOW
50 SMA$6.46-11.76%BELOW
100 SMA$5.84-2.32%BELOW
150 SMA$5.42+5.15%ABOVE
200 SMA$4.92+15.80%ABOVE

Price Performance

1D-25.0%
1W-19.8%
1M-9.8%
3M+12.9%
6M+14.7%
YTD-1.2%
1Y+59.2%
3Y+13.9%
52-Week Trading Range61% from low
$5.70
52W Low$2.58
52W High$7.68

Technical Indicators

RSI (14)BULLISH
69.9
305070
VCP ScoreCOOL
3/10
Base depth: 49.8%

Risk Profile

Beta
0.54
52W Vol
73%
ATR
$0.44
Max DD (1Y)
-26%

Volume Analysis

Today
5
50D Avg
343.0K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+160%
$0.06
Q2'25+228%
$0.12
Q3'25-59%
$0.17
Q4'25-33%
$0.26
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:+0.29%
3 Years:+0.05%
TTM:-0.89%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:+210.89%
TTM:+0.54%

Stock Price CAGR

10 Years:-18.63%
5 Years:-11.00%
3 Years:+13.88%
1 Year:+59.22%

Return on Equity

10Y Avg:-202.4%
5Y Avg:31.8%
3Y Avg:42.4%
Last Year:23.8%

Key Metrics

Market Cap$287M
Gross Margin74.5%
Net Margin13.6%
Piotroski F-Score7/9

More PBYI Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

PBYI vs RVMDRVMDINCYGMABEXEL

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 71 meansPBYI outperformed 71% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.54 means 46% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 7/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 3/10 with COOL status.

Frequently Asked Questions

Is PBYI in an uptrend right now?

PBYI has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is PBYI overbought or oversold?

PBYI's RSI (14) is 70. The stock is in neutral territory, neither overbought nor oversold.

Is PBYI outperforming the market?

PBYI has a Relative Strength (RS) Rating of 71 out of 99. PBYI is performing about average compared to the market.

Where is PBYI in its 52-week range?

PBYI is trading at $5.70, which is 74% of its 52-week high ($7.68) and 61% above its 52-week low ($2.58).

How volatile is PBYI?

PBYI has a Beta of 0.54 and 52-week volatility of 73%. It's less volatile than the S&P 500 - generally more stable.